Morphological, functional outcome and stability of the treat and extend protocol using aflibercept compared to ranibizumab for the treatment of eyes with neovascular age-related macular degeneration
Latest Information Update: 20 Aug 2019
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 20 Aug 2019 New trial record
- 01 Aug 2019 Results published in the Graefes Archive for Clinical and Experimental Ophthalmology